DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zhu AX, Rosmorduc O, Evans J , et al.
SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with hepatocellular carcinoma (HCC).
Ann Oncol 2012;
23 (Suppl. 09) Abstract LBA2
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.